For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
OncoDNA, the Cancer Theranostic Company, announced today that SHCHURKO A.V. will market and distribute OncoDNA’s complete solutions portfolio in Belarus. The whole range of OncoDNA’ services are now available for clinical use.
Belarusian oncologists and patients will have access to high-tech molecular profiling solutions that combine liquid and solid biopsies assays aspiring to improve the lives of patients with metastatic cancer. Precision and personalized medicine is already a reality and is now accessible to Belarusian metastatic cancer patients.
“With the recent advances in liquid biopsy testing and immunotherapy, we believe our solutions do bring new insight and useful clinical information to oncologists. Through our fast turnaround time and expert reports, our tests can also accelerate time to treatment, which is often of the essence for cancer patients. We are very happy to be able to offer our tests to cancer patients in Belarus through this agreement with Shchurko A.V.”, says Fiona Demol, International Business Development Manager at OncoDNA.
“It is a great honor for me to represent OncoDNA in the Belarusian market! I am confident that OncoDNA products will be in demand in Belarus, and doctors and patients will receive an additional tool for fighting cancer. We hope for long-term and fruitful cooperation.” Says Andrei Shchurko, CEO and founder.
If you are a medical doctor from Belarus and you would like to discuss about a project or collaboration opportunity, please contact OncoDNA’s local coordinator: Mr. Andrei Shchurko email: firstname.lastname@example.org Tel: +375 (33) 312-26-88
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.